AFT Pharmaceuticals Limited (AFT.NZ)

NZD 2.8

(0.0%)

Long Term Debt Summary of AFT Pharmaceuticals Limited

AFT Pharmaceuticals Limited's latest annual long term debt in 2024 was 28.2 Million NZD , down -12.42% from previous year.
AFT Pharmaceuticals Limited's latest quarterly long term debt in 2024 FY was 28.2 Million NZD , down -19.47% from previous quarter.
AFT Pharmaceuticals Limited reported annual long term debt of 35.02 Million NZD in 2023, down -2.63% from previous year.
AFT Pharmaceuticals Limited reported annual long term debt of 35.96 Million NZD in 2022, down -1.31% from previous year.
AFT Pharmaceuticals Limited reported quarterly long term debt of 31.39 Million NZD for 2024 Q3, down -15.06% from previous quarter.
AFT Pharmaceuticals Limited reported quarterly long term debt of 36.62 Million NZD for 2024 Q1, up 3.11% from previous quarter.

Annual Long Term Debt Chart of AFT Pharmaceuticals Limited (2024 - 2013)

Historical Annual Long Term Debt of AFT Pharmaceuticals Limited (2024 - 2013)

Year	Long Term Debt	Long Term Debt Growth
2024	28.2 Million NZD	-12.42%
2023	35.02 Million NZD	-2.63%
2022	35.96 Million NZD	-1.31%
2021	36.44 Million NZD	-18.47%
2020	44.69 Million NZD	0.0%
2019	- NZD	-100.0%
2018	30.65 Million NZD	30.85%
2017	23.42 Million NZD	12.27%
2016	20.86 Million NZD	0.61%
2015	20.73 Million NZD	57.87%
2014	13.13 Million NZD	4.8%
2013	12.53 Million NZD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 FY	28.2 Million NZD	-19.47%
2024 Q3	31.39 Million NZD	-15.06%
2024 Q1	36.62 Million NZD	3.11%
2024 Q4	28.2 Million NZD	0.0%
2024 Q2	33.2 Million NZD	0.0%
2023 Q3	35.02 Million NZD	600.4%
2023 Q4	35.02 Million NZD	0.0%
2023 FY	35.02 Million NZD	-2.63%
2023 Q1	7.59 Million NZD	-78.89%
2023 Q2	5 Million NZD	-34.14%
2022 Q1	39.19 Million NZD	7.54%
2022 Q4	35.96 Million NZD	0.0%
2022 Q3	35.96 Million NZD	-0.65%
2022 FY	35.96 Million NZD	-1.31%
2022 Q2	36.2 Million NZD	-7.63%
2021 Q2	34.7 Million NZD	-9.04%
2021 Q1	38.14 Million NZD	-14.65%
2021 Q3	36.44 Million NZD	5.02%
2021 Q4	36.44 Million NZD	0.0%
2021 FY	36.44 Million NZD	-18.47%
2020 Q4	44.69 Million NZD	0.0%
2020 Q2	3.63 Million NZD	0.0%
2020 Q1	3.63 Million NZD	0.0%
2020 FY	44.69 Million NZD	0.0%
2020 Q3	44.69 Million NZD	1130.25%
2019 Q4	- NZD	0.0%
2019 FY	- NZD	-100.0%
2019 Q3	- NZD	-100.0%
2019 Q2	41.93 Million NZD	0.0%
2019 Q1	41.93 Million NZD	36.81%
2018 Q1	23.24 Million NZD	-0.78%
2018 Q4	30.65 Million NZD	0.0%
2018 Q3	30.65 Million NZD	31.88%
2018 Q2	23.24 Million NZD	0.0%
2018 FY	30.65 Million NZD	30.85%
2017 FY	23.42 Million NZD	12.27%
2017 Q2	22.03 Million NZD	0.0%
2017 Q1	22.03 Million NZD	-4.84%
2017 Q3	23.42 Million NZD	6.29%
2017 Q4	23.42 Million NZD	0.0%
2016 Q3	23.16 Million NZD	-6.31%
2016 Q2	24.72 Million NZD	0.0%
2016 FY	20.86 Million NZD	0.61%
2016 Q4	23.16 Million NZD	0.0%
2016 Q1	24.72 Million NZD	19.2%
2015 Q4	20.73 Million NZD	0.0%
2015 Q1	- NZD	0.0%
2015 Q3	20.73 Million NZD	0.0%
2015 FY	20.73 Million NZD	57.87%
2014 FY	13.13 Million NZD	4.8%
2013 FY	12.53 Million NZD	0.0%

Peer Long Term Debt Comparison of AFT Pharmaceuticals Limited

Name	Long Term Debt	Long Term Debt Difference
Greenfern Industries Limited	- NZD	-Infinity%
Rua Bioscience Limited	- NZD	-Infinity%